REQUEST A DEMO
Total
USD $0.00
Search more companies

GUP Rk Karelfarm (ГУП Рк Карелфарм) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: GUP Rk Karelfarm Profile Updated: October 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

GUP Rk Karelfarm (ГУП Рк Карелфарм) is based in Russia. The head office is in Petrozavodsk. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on August 23, 2024. There was a net sales revenue increase of 58.49% reported in GUP Rk Karelfarm (ГУП Рк Карелфарм)’s latest financial highlights for 2024. There was a total negative growth of 7.16% in GUP Rk Karelfarm (ГУП Рк Карелфарм)’s total assets over the same period. The net profit margin of GUP Rk Karelfarm (ГУП Рк Карелфарм) increased by 1.06% in 2024.

Headquarters
Volodarskogo, 3
Petrozavodsk; Karelia Republic; Postal Code: 185005

Contact Details: Purchase the GUP Rk Karelfarm (ГУП Рк Карелфарм) report to view the information.

Basic Information
Registered Capital:
Purchase the GUP Rk Karelfarm (ГУП Рк Карелфарм) report to view the information.
Financial Auditors:
Purchase the GUP Rk Karelfarm (ГУП Рк Карелфарм) report to view the information.
Incorporation Date:
August 23, 2024
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Farmakom OOO
100%
Company Performance
Financial values in the chart are available after GUP Rk Karelfarm (ГУП Рк Карелфарм) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
58.49%
Total operating revenue
58.49%
Operating profit (EBIT)
-23.6%
Net Profit (Loss) for the Period
37.26%
Total assets
-7.16%
Total equity
-3.72%
Operating Profit Margin (ROS)
0.1%
Net Profit Margin
1.06%
Return on Equity (ROE)
3.3%
Quick Ratio
0.01%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?